Skip to main content
. 2022 Feb 23;12:3074. doi: 10.1038/s41598-022-05164-4

Figure 2.

Figure 2

Effects of miR-298 treatment on APP and BACE1 mRNA in astrocytes and differentiated neuroblastoma cells. (a, b) Astrocytes were transfected with miR-298 for 3 days. RNA was harvested for reverse transcription and following quantification by real-time qPCR. APP and BACE1 mRNA showed significant reduction when transfected with miR-298. (c,d) Real-time qPCR analysis in differentiated neuroblastoma cells transfected with miR-298. (e) Quantification of endogenous miR-298 levels in astrocytes U373 and NBRA differentiated SK-N-SH. MiR-298 levels were normalized with the geometric means of miR-16, RNU48 and RNU6B. Significant pairwise difference indicated by "*".